[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tempus AI Cl A (TEM)

Tempus AI Cl A (TEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,913,672
  • Shares Outstanding, K 178,774
  • Annual Sales, $ 1,272 M
  • Annual Income, $ -245,030 K
  • EBIT $ -253 M
  • EBITDA $ -146 M
  • 60-Month Beta 3.99
  • Price/Sales 6.95
  • Price/Cash Flow N/A
  • Price/Book 21.24

Options Overview Details

View History
  • Implied Volatility 70.92% (+2.71%)
  • Historical Volatility 78.00%
  • IV Percentile 27%
  • IV Rank 27.52%
  • IV High 97.96% on 05/28/25
  • IV Low 60.65% on 12/10/25
  • Expected Move (DTE 4) 3.10 (6.22%)
  • Put/Call Vol Ratio 0.63
  • Today's Volume 33,083
  • Volume Avg (30-Day) 26,023
  • Put/Call OI Ratio 0.67
  • Today's Open Interest 331,765
  • Open Int (30-Day) 294,874
  • Expected Range 46.76 to 52.96

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.25
  • Number of Estimates 4
  • High Estimate $-0.03
  • Low Estimate $-0.42
  • Prior Year $-0.36
  • Growth Rate Est. (year over year) +30.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.41 +17.57%
on 04/10/26
58.04 -14.09%
on 04/16/26
+2.36 (+4.97%)
since 04/08/26
3-Month
41.73 +19.48%
on 03/30/26
62.00 -19.58%
on 02/20/26
-5.05 (-9.20%)
since 02/06/26
52-Week
41.73 +19.48%
on 03/30/26
104.32 -52.20%
on 10/09/25
-15.36 (-23.55%)
since 05/08/25

Most Recent Stories

More News
Ambry Genetics’ CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”

Ambry Genetics, a leader in clinical genomic testing, and a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), today announced that its CARE Program (Comprehensive, Assessment, Risk,...

TEM : 49.86 (+0.79%)
Tempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior Notes

Tempus AI, Inc. (“Tempus”) (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the pricing of $400.0 million aggregate principal...

TEM : 49.86 (+0.79%)
Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense

- P roceeds expected to be used to repay in full outstanding loans under the senior secured credit facilities, reducing interest expense and enhancing financial flexibility. Additional...

TEM : 49.86 (+0.79%)
Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer’s Biomarker Testing into Clinical Workflows

Agreement supports the identification of patients eligible for Alzheimer’s disease biomarker testing through Tempus Next and enables neurologists to order LucentAD® Complete on Tempus’ clinical ordering...

TEM : 49.86 (+0.79%)
QTRX : 2.83 (+2.73%)
Tempus: Q1 Earnings Snapshot

Tempus: Q1 Earnings Snapshot

TEM : 49.86 (+0.79%)
Tempus Reports First Quarter 2026 Results

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today reported financial results for the quarter ended March 31, 2026. ...

TEM : 49.86 (+0.79%)
Tempus AI's Path to Profitability Reaches Its First Real Checkpoint

Barchart Research What to Expect from TEM Earnings TEM Generated May 4, 2026 Current Price $55.81 EPS Estimate $$-0.47 Consensus Rating Moderate Buy Average Move 7.47% Tempus AI's Path to Profitability...

TEM : 49.86 (+0.79%)
Tempus to Host Inaugural Investor Day on May 29, 2026

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that the company will host an Investor Day on Friday, May 29, 2026. The event...

TEM : 49.86 (+0.79%)
Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026

Tempus AI, Inc. (NASDAQ: TEM), a technology company advancing precision medicine through the practical application of artificial intelligence, today announced it has been named to TIME’s 10 Most...

TEM : 49.86 (+0.79%)
Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and the Keck School of Medicine of USC and Keck Medicine of USC, today announced a multi-faceted...

TEM : 49.86 (+0.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery,...

See More

Key Turning Points

3rd Resistance Point 54.06
2nd Resistance Point 51.97
1st Resistance Point 50.92
Last Price 49.86
1st Support Level 47.78
2nd Support Level 45.69
3rd Support Level 44.64

See More

52-Week High 104.32
Fibonacci 61.8% 80.41
Fibonacci 50% 73.03
Fibonacci 38.2% 65.64
Last Price 49.86
52-Week Low 41.73

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.